MGMT and breast cancer: Jarmalaite et al (23) studied promoter hypermethylation of the p16, RARβ, RASSF1A, DAPK and MGMT genes in patients with BC, and hypermethylation of the RASSF1A gene was more frequently detected in muscle-invasive tumors compared with non-invasive tumors.